A Tulsa pain management practice whose website lists stem cell and exosome treatment among its services, described only in general terms.
Memorial Pain Clinic is a pain management practice at 8131 South Memorial Drive, Tulsa, Oklahoma, with telephone numbers (918) 200-9944 and a freephone line of (877) 616-3089. Its main business is interventional pain management, with regenerative medicine presented as one section of the site. Four clinicians are listed - a board-certified pain physician, a second doctor, a physician assistant and an advanced practice registered nurse - although every biography on the provider page simply reads that it is coming soon, so there is no information about their training or experience on the site itself.
The regenerative medicine page is unusual, and a reader should treat it with care. Rather than describing what the clinic actually does, it reads as a general essay on the field: it lists stem cell therapy, tissue engineering, gene therapy, biomaterials and scaffold-based treatments and exosome therapy, and discusses adult stem cells from bone marrow alongside human embryonic stem cells. Gene therapy, scaffolds and embryonic cells are not treatments a pain clinic would provide, so it is not possible to tell from this page which of these are genuinely on offer. The page also does not say whether the cells used in any treatment come from the patient's own body or from a donor, noting only that both are possible in general.
For exosome therapy - exosomes being tiny packets released by cells - the page gives no source, no supplier and no regulatory information. For stem cell treatment it gives no account of how material would be collected, processed or injected, and no description of the assessment a patient would have first. The conditions mentioned range from arthritis, degenerative disc disease, neuropathic pain and joint pain to orthopaedic, neurological, cardiovascular and autoimmune disease in general, which again reads as a description of the field rather than of this clinic's practice.
The practical consequence is that anyone considering cell treatment here would need to ask the clinic directly what it actually offers, what the material is, where it comes from, who supplies it and what its regulatory status is, because none of that can be established from the website. No prices are published and the site says nothing about insurance cover, so a written quotation should be requested as well. The clinic's conventional pain management services are described more concretely, and a patient may find it more useful to ask how the proposed injection compares with those.
The conditions named on the regenerative medicine page range from specific pain problems to whole categories of disease, and should be read as a general list rather than a statement of what the clinic treats with cell therapy.
The site discusses stem cells in general terms - adult cells from bone marrow and human embryonic cells - without saying which, if either, it uses, or whether material would come from the patient's own body or from a donor.
Four clinicians are listed, but every biography on the site is marked as coming soon, so no training or experience details are given.
The clinic is described as a single outpatient pain practice at 8131 South Memorial Drive in south Tulsa, offering consultations and injection-based pain treatment. The site gives no description of the premises, no information about procedure rooms or imaging guidance, and no detail of where any blood, marrow or cell product would be handled or processed. No accreditation or certification is stated, no founding year is given and the languages spoken are not mentioned. Contact is by telephone on the local or freephone numbers listed.
No prices are published and the site makes no statement about insurance cover for stem cell or exosome treatment. Because the practice also provides conventional pain procedures that would normally be billed to insurance, a prospective patient should ask which parts of any proposed treatment are insured and which must be paid privately, and insist on a written quotation.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.